NCT02084069View on ClinicalTrials.gov

Atrovastatin for Preventing Atrial Fibrillation Following Open Cardiac Valve Repair

PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Heart Valve Diseases
Interventions
DRUG

Atorvastatin

Trial Locations (1)

Unknown

Seyyed-al-Shohada Heart Center, Urmia

All Listed Sponsors
lead

Urmia University of Medical Sciences

OTHER

NCT02084069 - Atrovastatin for Preventing Atrial Fibrillation Following Open Cardiac Valve Repair | Biotech Hunter | Biotech Hunter